HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Beaudeux, J.-L. Articles by Foglietti, M.-J. Search for Related Content PubMed PubMed Citation Articles by Beaudeux, J.-L. Articles by Foglietti, M.-J. Related Collections Proteomics and Protein Markers

Influence of Hemolysis on the Measurement of S-100ß Protein and Neuron-specific Enolase Plasma Concentrations during Coronary Artery Bypass Grafting

¹ Fédération de Biochimie,
² Département d’Anésthésie-Réanimation, and
³ Service de Chirurgie Cardiaque, Hôpital Pitié-Salpêtrière, 47-83 Boulevard de l’Hôpital, F75651 Paris Cedex 13, France
^a author for correspondence: fax 33-1-42-17-76-16, e-mail jean-louis.beaudeux@psl.ap-hop-paris.fr

Cerebral injury is an important complication after cardiovascular surgery. The neurological events usually are diagnosed using rather crude psychometric tests and clinical observations (1). Biological markers have been proposed to detect cerebral damage during cardiac surgery, e.g., the creatine kinase BB isoform or neuron-specific enolase (NSE). Because of its neurospecificity, the isoform of enolase is of particular interest. Measurements in biological fluids use -subunit-specific immunoassays. Because of the abundance of the isoform of enolase in erythrocytes, systemic NSE values may be falsely increased by the frequent hemolysis that occurs during surgery (2)(3).

S-100ß protein (S-100) is a member of a family of calcium-binding proteins present primarily in nervous tissue, where it is concentrated mainly in glial cells. Although the role of this protein in brain function and disease has not been elucidated conclusively, it has been ascertained that the appearance of this protein constituent of neural cells in biological fluids is a reliable indicator of active cell damage in the nervous system in different pathological conditions. Measurement of S-100 in the blood recently has been used successfully to monitor cerebral damage after cardiac surgery (4)(5)(6). S-100 is absent from red blood cells (RBCs), and plasma concentrations would not be influenced by hemolysis.

We examined the reliability of measurements of plasma S-100 in either in vivo or ex vivo hemolyzed blood samples. Blood samples were taken from 24 patients (19 males and 5 females; age, 63.4 ± 9.8 years, mean ± SD), who were undergoing coronary artery bypass . . . [Full Text of this Article]

References

The following articles in journals at HighWire Press have cited this article:

				J. Reisinger, K. Hollinger, W. Lang, C. Steiner, T. Winter, E. Zeindlhofer, M. Mori, A. Schiller, A. Lindorfer, K. Wiesinger, et al. Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase Eur. Heart J., January 1, 2007; 28(1): 52 - 58. [Abstract] [Full Text] [PDF]

				O. F. Laterza, V. R. Modur, D. L. Crimmins, J. V. Olander, Y. Landt, J.-M. Lee, and J. H. Ladenson Identification of Novel Brain Biomarkers Clin. Chem., September 1, 2006; 52(9): 1713 - 1721. [Abstract] [Full Text] [PDF]